龍光集團(3380.HK)中期派息率約40% 累計股票分紅已超IPO價
格隆匯8月21日丨龍光集團(3380.HK)今日公佈2020年中期業績。為回饋股東支持,公司宣佈,派現金中期股息每股43港仙,派息額佔歸母核心利潤約40%,這也是龍光連續5年派息比率達40%。以業績發佈前一天收盤價計算,龍光期內股息收益率達6.2%,股息率優勢顯著,投資價值突出。自上市以來,龍光始終堅持持續優厚的派息政策,每年都推出分紅方案,股息收益率居行業前列,連續入選恆生高股息指數成分股。截至2020年中期,龍光每股分紅累計達3.03港元,已遠超公司IPO價格,給投資者帶來可觀的長期投資收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.